OCSOculis Holding AG
$11.28
$0.555
(4.69%)
Reported EarningsMay 11
Mkt Cap$676.31M
Vol696,516.00
Fundamentals
Mkt Cap
$676.31M
Volume
-
52W High
$34.48
52W Low
$11.31
PE Ratio
-5.53
Avg. Volume
539,962.70
EPS (Annual)
-$2.28
Rev/Employee
$0.00
Earnings
May 11
90
Extremely Bullish Sentiment
How do you feel about OCS?
OCS Investors Have Opportunity to Join Oculis Holding AG Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Oculis Holding AG (Oculis or the Company) (NASDAQ: OCS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or...
Business Wire
OCS Investor Alert: Levi & Korsinsky Investigates Oculis Holding AG (OCS) for Potential Securities Fraud
Shareholders of Oculis Holding AG (NASDAQ: OCS) lost nearly $7 per share, more than 23%, in a single trading session when the company disclosed that its Phase 3 DIAMOND-1 and DIAMOND-2 trials for OCS-01 failed to meet the primary endpoint -- mean change in best-corrected visual acuity at week 52...
Business Wire
OCS SHAREHOLDER INVESTIGATION: SueWallSt Investigates Oculis Holding AG for Possible Securities Law Violations
OCS SHAREHOLDER INVESTIGATION: SueWallSt Investigates Oculis Holding AG for Possible Securities Law Violations OCS SHAREHOLDER INVESTIGATION: SueWallSt Investigates Oculis Holding AG for Possible Securities Law Violations PR Newswire NEW YORK, June 2, 2026 Oculis Holding AG claimed its "most...
PR Newswire
Oculis Holding AG Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Oculis Holding AG (OCS)
Oculis Holding AG Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Oculis Holding AG (OCS) Oculis Holding AG Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Oculis Holding AG (OCS) PR Newswire NEW YORK, June 1, 2026 Oculis...
PR Newswire
Oculis Holding AG (OCS) Reports Q1 Loss, Lags Revenue Estimates
Oculis Holding AG (OCS) delivered earnings and revenue surprises of -27.71% and -17.08%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Insmed (INSM) Reports Q1 Loss, Misses Revenue Estimates
Insmed (INSM) delivered earnings and revenue surprises of +15.86% and -0.70%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
TG Therapeutics (TGTX) Q1 Earnings Lag Estimates
TG Therapeutics (TGTX) delivered earnings and revenue surprises of -26.88% and +2.81%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Oculis (OCS) to Release Earnings on Monday
Oculis (NASDAQ:OCS) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-oculis-holding-ag-stock...
MarketBeat
Gildi lifeyrissjodur Makes New Investment in Oculis Holding AG $OCS
Gildi lifeyrissjodur acquired a new stake in shares of Oculis Holding AG (NASDAQ:OCS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,447,985 shares of the company...
MarketBeat
<
1
2
...
>
Advertisement|Remove ads.
Latest OCS News
ViewOCS Investors Have Opportunity to Join Oculis Holding AG Fraud Investigation with the Schall Law Firm
Business Wire
OCS Investor Alert: Levi & Korsinsky Investigates Oculis Holding AG (OCS) for Potential Securities Fraud
Business Wire
OCS SHAREHOLDER INVESTIGATION: SueWallSt Investigates Oculis Holding AG for Possible Securities Law Violations
PR Newswire
Advertisement|Remove ads.